CpG Diagnostics
CpG Diagnostics offers a blood test platform for early detection of ovarian cancer using cell-free DNA. The test analyzes DNA methylation patterns with machine learning to distinguish cancer from benign conditions. Core technologies include machine learning, genomics, epigenomics, and analysis of cell-free DNA. The flagship product, OvaPrint, targets women with pelvic masses and integrates into diagnostic workflows through collaboration with clinicians and healthcare organizations. The company aims to improve early detection, guide treatment planning, and expand to additional cancer types as it scales.
CpG Diagnostics
CpG Diagnostics offers a blood test platform for early detection of ovarian cancer using cell-free DNA. The test analyzes DNA methylation patterns with machine learning to distinguish cancer from benign conditions. Core technologies include machine learning, genomics, epigenomics, and analysis of cell-free DNA. The flagship product, OvaPrint, targets women with pelvic masses and integrates into diagnostic workflows through collaboration with clinicians and healthcare organizations. The company aims to improve early detection, guide treatment planning, and expand to additional cancer types as it scales.